Dr. Otto Yang was also interviewed today though the focus

New Post Public Reply Private Reply Replies (1) Message Board
drfreak1
866
Dr. Otto Yang was also interviewed today though the focus was on COVID-19 in general and not leronlimab.

The situation sounds critical - "people are overworked and overwhelmed"

Here is hoping leronlimab becomes more readily available where and when needed.

https://finance.yahoo.com/video/people-overwo...58144.html

Yahoo Finance Video
‘People are overworked and overwhelmed’: Doctor on the state of covid-19 in California hospitals

Thu, December 24, 2020, 12:28 PM EST

Dr. Otto Yang, Professor of Medicine and Infectious Diseases at David Geffen School of Medicine at UCLA, joins Yahoo Finance’s Julia La Roche and Adam Shapiro to discuss her thoughts on the coronavirus pandemic and the state of California as it faces another spike in cases.

Video Transcript
JULIA LA ROCHE: As the US deals with the latest surge in COVID-19 cases, California has been especially hit hard. I'd like to bring into the stream Dr. Otto Yang, Professor of Medicine and Infectious Diseases at the David Geffen School of Medicine at UCLA. Dr. Yang, thank you so much for joining us. Of course, a lot of folks were talking about California and the holiday surge there.

Can you contextualize for our viewers what is happening in California as it relates to COVID-19?

OTTO YANG: Well, we've been hit with a flood of COVID cases, far exceeding anything that we saw before. And our hospitals are basically all full.

ADAM SHAPIRO: What is this like for you personally? I mean, we can't imagine the horror of this.

OTTO YANG: I'm fortunate because I'm more of a researcher. And I spend less time on the front lines than many of my colleagues. But the full time physicians who are seeing patients day to day, and the nurses, and the respiratory therapists, and all the staff in the hospitals, I think it's-- it's a horrifying experience for them, very stressful. Staffing is the limiting factor. We have enough rooms. We have enough ventilators. But staffing, we just-- people are overworked and overwhelmed.

JULIA LA ROCHE: Dr. Yang, what do you attribute this to? Is this from the Thanksgiving holiday travel that folks were warned about not to travel at that time, and now we're starting to see that manifest itself, that timeline that had been put out there. Is that what you think this is really from?

OTTO YANG: I think that's a large factor. Yes, that and loosening of policies leading up to Thanksgiving. And I think also just people reaching fatigue in terms of following guidelines to distance and mask and protect themselves.

ADAM SHAPIRO: What are your colleagues telling you about the ability-- there are other issues that hit people medically. Do the hospitals have the room to take somebody who might, God forbid, be in cardiac arrest or other kinds of emergencies?

OTTO YANG: They, of course, have no choice but to take somebody that's in that type of dire circumstance. But there's a big trickle down effect, right. So elective surgeries or elective procedures are all being delayed to conserve space in the hospital for sick patients. So it-- you know, we saw this earlier that when the hospitals started to get a bit full, that cancers were being diagnosed later or treated later.

And I think we're going to see much of the same and patients not coming in. Because they're-- the hospitals are full, and the clinics are closed.

JULIA LA ROCHE: Dr. Yang, for folks watching, if you could share some sort of message or plea for the public, what would you say to them?

OTTO YANG: I would say to, you know, listen to-- to the people on the front lines, the physicians, and the scientists and to take this seriously. It's boggles my mind that, to this day, there are still conspiracy theories floating around and people who are denying this and saying it's just like the flu. You know, this clearly is not something to be taken lightly.

And as a society, we should not be in this situation where we don't take something seriously unless it affects us personally. We need to be thinking about this as a society. And this needs to be above politics. This needs to be independent of political beliefs or political feelings.

ADAM SHAPIRO: We're seeing now what, I guess, is the wave after the Thanksgiving mistakes that people made. And now we have people, more than a million people, traveling every day since last Thursday. How bad will this get in a couple of weeks after the Christmas holiday break?

OTTO YANG: I am afraid even to try to imagine it. But it certainly-- it seems like we're on pace for it to get much, much worse. Things have only continued to ramp up. And if the predictions about people traveling for Christmas and getting together for Christmas are accurate, we're going to see as big a wave as from Thanksgiving. And so this is really going to be a huge problem.

And I think we're going to start seeing mortality rates creep up. So, you know, each patient-- part of the reason that things have improved in terms of mortality is that doctors have gotten much better at knowing how to treat the disease. But if hospitals and the hospital staff are overwhelmed, all that's going to go out the window. And mortality rates are going to climb drastically.

JULIA LA ROCHE: You know, let's talk about maybe from what should be done to kind of help limit some of this. Do we need more travel restrictions? What kind of measures could help mitigate the situation in California?

OTTO YANG: Well, certainly leadership from above would be helpful. And that's been a weak point in dealing with this pandemic that has been especially bad in this country, unfortunately. I think, at this point, to some extent, we're on our own. And we need to exercise personal responsibility. So really, the basics have not changed. So people talk about how recommendations have flip-flopped, and the scientific data have changed. That's actually not true.

The basics about how this virus have been the same since March, in terms of what people have been saying. It's really the simple basics, right, so mask wearing as much as possible, physical distancing, trying to keep events outdoors, avoiding crowded indoor spaces, avoiding meeting with people in large groups. I mean, these are really simple basics and based on what we understand of the virus and how it's spread.

JULIA LA ROCHE: Dr. Otto Yang, Professor of Medicine and Infectious Diseases at David Geffen School of Medicine at UCLA, thank you so much for taking the time and wishing you a happy and healthy holiday season and new year.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading

Top 5 Most Recently Viewed Articles

Hofseth BioCare ASA Secures Funding Through Private Placement

Updated Category News Views 216

Hofseth BioCare ASA Successfully Completes a Private Placement Hofseth BioCare ASA, often referred to as HBC, has recently completed a significant private placement aimed at enhancing its growth capital and strengthening its corporate balance sheet. This strategic move is set to fund the company's ongoing developments and initiatives effectively. The Details of the...

Continue Reading
Prosus N.V. Announces Limit for Tender Offer Notes

Updated Category News Views 78

The Brass Tacks of Prosus's Recent Move Today, Prosus N.V. put a definitive cap on its cash tender offer, inviting investors to sell back their notes due in 2027. What’s happening under this financial tablecloth? We’re diving into a U.S.$1,035,854,000 cap on the tendered notes—shaved down from their new senior notes total of U.S.$1,650,000,000. Decoding the Offer:...

Continue Reading
Growth Potential of the Asia Pacific Conference Room Solutions Market

Updated Category News Views 119

Understanding the Growth in the Asia Pacific Conference Room Solutions Market The Asia Pacific conference room solutions market is on a remarkable growth trajectory, with valuations surging from US$ 300.08 million in 2023 to a stunning US$ 1,922.25 million projected by 2032, at a compound annual growth rate (CAGR) of 23.79%. This surge can be attributed to several...

Continue Reading
BexBack Launches High-Leverage Trading with Exciting Bonuses

Updated Category News Views 176

Exciting New Trading Features from BexBack BexBack, a leading cryptocurrency exchange platform, is thrilled to reveal its latest trading enhancements, designed for traders eager to amplify their market position. These innovative features are now accessible to users across the globe, marking a significant step in meeting the soaring demand for high-leverage crypto trading....

Continue Reading
NexGen Health Achieves Milestone with Stellar Customer Reviews

Updated Category News Views 200

NexGen Health Celebrate Customer Satisfaction Milestone Leading Silicon Valley wellness clinic's exceptional patient reviews emphasize their commitment to cutting-edge IV therapy, personalized care, and innovative health solutions. NexGen Health, Silicon Valley's premiere wellness and anti-aging clinic, proudly announces a significant customer satisfaction milestone with...

Continue Reading